Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 414 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical Cystectomy

NCT03404791

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • North Georgia Urology Center Dalton, Georgia, United States
  • Chesapeake Urology Research Associates Hanover, Maryland, United States
  • Michigan Institute of Urology Troy, Michigan, United States
View Trial Details
Completed

Lidocaine Patches Prior to Percutaneous Nerve Evaluation

NCT05783219

Conditions
Digestive System Diseases, Fecal Incontinence, Female Urogenital Diseases, +18 more
Locations
  • ULP Female Pelvic Medicine and Reconstructive Surgery - Springs Medical Center Suite 190 Louisville, Kentucky, United States
  • ULP Female Pelvic Medicine and Reconstructive Surgery - Urogynecology Associates office Louisville, Kentucky, United States
View Trial Details
Completed

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

NCT05085990

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Tulane Medical Center (TMC) - Clinic/Outpatient Facility New Orleans, Louisiana, United States
  • Chesapeake Urology Research Associates Baltimore, Maryland, United States
View Trial Details
Completed

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)

NCT05085977

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Tulane Medical Center New Orleans, Louisiana, United States
  • Chesapeake Urology Research Associates Baltimore, Maryland, United States
View all 14 locations
View Trial Details
Completed

Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer

NCT02662062

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
View Trial Details

Related conditions